Loading...

Decreased expression of MT1E is a potential biomarker of prostate cancer progression

Differentiation of indolent and aggressive prostate carcinoma (PCa) at the time of diagnosis is currently one of the major challenges. This study aimed at identification of prognostic biomarkers to aid in predicting biochemical recurrence (BCR) of the disease. Microarray-based gene expression profil...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Demidenko, Rita, Daniunaite, Kristina, Bakavicius, Arnas, Sabaliauskaite, Rasa, Skeberdyte, Aiste, Petroska, Donatas, Laurinavicius, Arvydas, Jankevicius, Feliksas, Lazutka, Juozas R., Jarmalaite, Sonata
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2017
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5617458/
https://ncbi.nlm.nih.gov/pubmed/28977898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18683
Tags: Add Tag
No Tags, Be the first to tag this record!